Results 111 to 120 of about 1,070 (196)

Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances. [PDF]

open access: yesJ Eur Acad Dermatol Venereol, 2022
Ständer S   +8 more
europepmc   +1 more source

Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis. [PDF]

open access: yesBr J Clin Pharmacol
Fauchet F   +17 more
europepmc   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study. [PDF]

open access: yesJ Eur Acad Dermatol Venereol
Augustin M   +24 more
europepmc   +1 more source

Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents. [PDF]

open access: yesDermatol Ther (Heidelb), 2022
Sidbury R   +9 more
europepmc   +1 more source

Patient Perspectives on Living With Severe Prurigo Nodularis.

open access: yesJAMA Dermatol, 2023
Rodriguez D   +6 more
europepmc   +1 more source

Testing hypotheses about the harm that capitalism causes to the mind and brain: a theoretical framework for neuroscience research. [PDF]

open access: yesFront Sociol, 2023
Kokorikou DS   +7 more
europepmc   +1 more source

Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA). [PDF]

open access: yesPatient
Silverberg JI   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy